BTG3 and autoimmune disease: The prevalence of preexisting autoimmune disease and elevated ANA titer >1:160 in our cohort of “long haulers” compared to the general population (16% vs. 7% and 33% of those tested vs. 5%, respectively)47, 48 suggests the possibility of an autoimmune contribution.